# Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/genomic-characterisation-of-de-novo-egfr-copy-number-gain-and-its-impact-on-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yiquan Xu,Jingjing Yan,Chengzhi Zhou,Lin Wu,Haibo Wang,Jun Zhao,Maolin Zhou,Jingyi Wang,Xinlong Zheng,Longfeng Zhang,Kan Jiang,Xiaobin Zheng,Qian Miao,Shiwen Wu,Zihua Zou,Rong Lian,Yuange He,Rongrong Chen,Shanshan Yang,Yujing Li,Sihui Chen,Gen Lin |
| Citations | 5 |
| DOI | 10.1016/j.ejca.2023.04.009 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4366496734 |
| PMID | 37201385 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Xinlong Zheng](https://scholariq.org/researchers/xinlong-zheng/)

## Paper journal

- [European Journal of Cancer](https://scholariq.org/journals/european-journal-of-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.